Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII

NCT00284193 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT00284193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00284193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII
Lead sponsor
Sheba Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2005
Completion date
November 30, 2009
Enrollment
5 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a